OxStem Ltd, an Oxford University spinout developing regenerative medicine-based therapies, is launching two subsidiary companies to develop regenerative treatments for diabetes and chronic inflammation and wound healing.
Regenerative medicine spinout OxStem launches subsidiaries
Innovation
5 October 2018
Subsidiaries of the Oxford University spinout, OxStem Immuno and OxStem Beta, will draw on research from the institution.
![Oxstem logo](https://www.medsci.ox.ac.uk/images/news/oxstem-logo1-160x160.jpg/responsive_image?ratio=image&scale=w760)